Covaxin phase 3 data shows 77.8% efficacy: Lancet
Hyderabad: A week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, a prestigious medical journal Lancet has stated that the phase 3 data of India’s first indigenously developed vaccine demonstrates…